CHICAGO, IL - AUGUST 19, 2024 - The Consortium for Technology & Innovation in Pediatrics (CTIP), centered at Ann & Robert H. Lurie Children's Hospital of Chicago, awarded $160,000 in seed grants on August 19, 2024, to accelerate medical device projects specifically designed to improve the safety and delivery of care to infants and children.
Four innovators developing novel devices and technologies for pediatric patients were selected as winners for CTIP’s eighth annual Catalyzing Pediatric Innovation (CPI) Grant competition.
Children have long been an underserved population in the technology space, often having to deal with medical devices that were never designed for them and lack of access to diagnostics and therapeutics that meet their specific needs. The Consortium for Technology & Innovation in Pediatrics (CTIP) aims to change that by supporting pediatric device innovators from concept to commercialization through funding, advising, networking, and advocacy.
CTIP received over 80 Letters of Intent for our 2024 Catalyzing Pediatric Innovation Grant and is excited to share the many innovative products and concepts submitted for application in the pediatric medical device space. Applications included device projects across 37 different pediatric subspecialties, all anticipated FDA device classes (Class I, II, and III), and were received from 24 states, including 36% of applications from California.
The 2024 winners are as follows:
Revolutionizing Pediatric Heart Transplantation using the VP.S ENCORE® PEDS™ Device. This device doubles the preservation time with the perfusion of hypothermic, oxygenated, acellular (no blood) nutrient rich solution to the coronary arteries.
LinkedIn: Vascular Perfusion Solutions Twitter/X: Vascular Perfusion Solutions
Eysz Attention Tracker is a smartphone-based screening tool to assist clinicians in identifying children with Childhood Absence Epilepsy.
LinkedIn: Eysz Facebook: Eysz Instagram: Eysz
Smart Auto-Adjusting Stiffness AFO with an adjustable pivot point, walking speed estimator and modular, interchangeable components so that the device can grow with the child.
LinkedIn: Biomotum Facebook: Biomotum Instagram: Biomotum Twitter/X: Biomotum
Breath Monitor for Necrotizing Enterocolitis enables bedside detection of early-stage NEC based on breath hydrogen (H2), a bacterial metabolite whose measurement can serve as a proxy for bacterial overgrowth.
LinkedIn: https://www.linkedin.com/in/julianaperl/
For more updates from CTIP about pediatric MedTech follow us @ctipmedtech on Twitter, Facebook & Instagram, Consortium for Technology & Innovation in Pediatrics on LinkedIn, and the web at www.ctipmedtech.org